Edition:
India

I'rom Group unit concludes iPS cell generation technology licensing agreement with Evotec International GmbH


Wednesday, 16 May 2018 

May 16 (Reuters) - I'rom Group Co Ltd <2372.T>:Says its unit ID Pharma Co., Ltd. concluded an iPS cell generation technology related licensing agreement with Germany company Evotec International GmbH .Says its unit will receive upfront payment and annual royalty from Evotec International GmbH . 

Company Quote

20.72
-0.22 -1.05%
20 Sep 2019